Clinical Trials Logo

Clinical Trial Summary

The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The investigators are particularly interested in finding the genes that cause pancreatic cancer to cluster in some families. Up to 10% of pancreatic cancer patients have another close relative who has also developed pancreatic cancer. This clustering of pancreatic cancers in families has yet to be explained; however, the investigators continue to identify new familial pancreatic cancer genes that explain this clustering in subsets of families. For example, in 2009 and 2012 the investigators discovered that mutations in the PALB2 and ATM genes jointly account up to 5% of the clustering of pancreatic cancer in families.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02886247
Study type Observational
Source Johns Hopkins University
Contact Alison Klein, PhD, MHS
Phone 410-955-3502
Email pancreas@jhmi.edu
Status Recruiting
Phase
Start date June 1994
Completion date December 2032